Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.

about

Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.

Item

http://www.wikidata.org/entity/Q36963171

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.

@en

type

Item

label

Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.

@en

prefLabel

Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.

@en

P1476

Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.

@en

P2093

Anjali Shah

http://www.w3.org/2001/XMLSchema#string

Elliot M Frohman

http://www.w3.org/2001/XMLSchema#string

Eric Eggenberger

http://www.w3.org/2001/XMLSchema#string

P2860

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.

The mechanism of action of methylprednisolone in the treatment of multiple sclerosis.

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.

Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice.

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b.

Effects of combination therapy of beta-interferon 1a and prednisone on serum immunologic markers in patients with multiple sclerosis.

P2888

j.nurt.2007.07.009

P304

627-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NURT.2007.07.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olaf Stüve

Robert Zivadinov

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5923593

http://www.w3.org/2001/XMLSchema#string

P6179

1013901527

http://www.w3.org/2001/XMLSchema#string

P698

17920543

http://www.w3.org/2001/XMLSchema#string